PUBLIC COMPANY
saveMassachusetts General Hospital
updated 2mo ago
Massachusetts General Hospital is a teaching hospital located in the West End neighborhood of Boston, Massachusetts. It is the original and largest clinical education and research facility of Harvard Medical School/Harvard University, and houses the world's largest hospital-based research program with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds.
community read0 votes
🐶 often sniffed alongside
top 8- tagPulmonology8 co-mentions · 6 sources
- tagPain3 co-mentions · 2 sources
- tagMonoclonal Antibody2 co-mentions · 2 sources
- tagType 2 Diabetes2 co-mentions · 1 sources
- tagAlzheimer's Disease2 co-mentions · 2 sources
- drugAlzheimer's Disease2 co-mentions · 2 sources
- tagOncology2 co-mentions · 2 sources
- tagOphthalmology1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
48
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Abatacept in Immune Checkpoint Inhibitor Myocarditis
- N/ABrostrom Chronic Lateral Ankle Instability Repairs Augmented With BioBrace®
- N/AStandardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative
- EP1Niraparib In Recurrent IDH 1/2 Gliomas
- phase2Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL
- N/AThromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
- phase2Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
- phase4Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
🐶 Hiring Signal
News
- Replimune’s twice-rejected melanoma drug prevails in FDA adcommFollowing a pair of FDA rejections of its melanoma drug, Replimune’s fortunes flipped today after an advisory committee voted 10 to 3 in favor of the candidate’s effectiveness.fiercebiotech · 21d ago
- After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenGrowing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.stat · 23d ago
- Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effectsA new analysis of patients who took part in clinical trials for Kite Pharma’s CAR-T cell therapy Yescarta has revealed genetic signatures of toxicity risk, potentially providing a path forward for…fiercebiotech · 27d ago
- Opinion: Your grandparents are using cannabis. Doctors can help them do it safelyOver the past 25 years, I have treated thousands of medical cannabis patients with extremely few ill effects, one doctor writes.stat · 1mo ago
- Major readouts from the annual diabetes conferenceWhy "Schedule F" matters, the Ebola outbreak response, and more health news from Morning Roundsstat · 2mo ago
- When it’s time to save a limb, novel clinic meets unhoused people where they areUnmet vascular needs can lead to limb loss among unhoused patients. An unusual Massachusetts General Hospital program meets patients where they are.stat · 2mo ago
- Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal CancerAparna R. Parikh, MD, discusses how trials like PODIUM-303 are reshaping the treatment paradigm for squamous cell anal carcinomas.onclive · 3mo ago
comments(0)
5-min edit window · permanent after that